DarioHealth Corp. DRIO
6.63
(0.14)
(2.07%)
as of 25 Sep
- Market cap
- $66.3M
- P/E
- 0.0×
Follow DRIO
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(95.54%) | (88.23%) | (82.18%) | (76.05%) | |
| (55.99%) | (53.93%) | (51.09%) | (44.19%) | ||
ROIC |
(33.85%) | (31.63%) | (29.57%) | (27.67%) | |
Return on Tangible Assets |
(190.37%) | (234.80%) | (281.16%) | (346.95%) | |
Average Days of Receivables |
76.55 | 73.54 | 74.03 | 72.19 | |
Free Cash Flow per Share |
(8.58) | (6.55) | (3.86) | (2.73) | |
Free Cash Flow |
(26.92) | (26.08) | (25.43) | (25.47) | |
Capital Expenditures |
(0.14) | (0.14) | (0.14) | (0.13) | |
Piotroski F-Score |
5.00 | 3.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(19.46%) | (20.77%) | (22.27%) | (25.24%) | |
Accounts Receivable Turnover |
3.65 | 3.84 | 4.16 | 4.40 | |
Accounts Payable Turnover |
3.48 | 3.25 | 2.96 | 2.68 | |
Inventory Turnover |
2.22 | 2.14 | 2.09 | 2.11 | |
Average Days of Payables |
118.68 | 110.25 | 137.47 | 131.79 | |
Days of Inventory on Hand |
166.57 | 162.51 | 165.38 | 154.46 | |
Tax Rate |
0.00 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
66.46% | 61.68% | 56.95% | 49.75% | |
Selling, General and Administrative Expense of Revenue |
151.16% | 158.90% | 162.66% | 160.00% | |
Share Based Compensation of Revenue |
40.10% | 41.88% | 39.94% | 33.63% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.42 | 0.42 | 0.45 | 0.56 | |
Depreciation/Fixed assets |
7.60 | 5.72 | 4.71 | 4.21 | |
Capex/Depreciation |
(0.03) | (0.05) | (0.06) | (0.06) | |
Revenue per Share |
7.88 | 5.61 | 3.22 | 2.25 | |
Operating CF per Share |
(8.54) | (6.51) | (3.84) | (2.71) | |
Capex per Share |
(0.04) | (0.04) | (0.02) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(257.74%) | (276.11%) | (263.88%) | (215.63%) |
Columns are period end dates